• Fri, September 9, 2022

Matthew Harrison Maintained (ALVR) at Buy with Decreased Target to $27 on, Sep 9th, 2022

Matthew Harrison of Morgan Stanley, Maintained "AlloVir, Inc." (ALVR) at Buy with Decreased Target from $32 to $27 on, Sep 9th, 2022.

Matthew has made no other calls on ALVR in the last 4 months.



There are 2 other peers that have a rating on ALVR. Out of the 2 peers that are also analyzing ALVR, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $23 on, Thursday, July 28th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $34 on, Thursday, May 19th, 2022

Like: 👍